Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

South Africa Announces AIDS Drug Venture With Swiss Lonza

February 13, 2012

Talks are underway between the Swiss drug maker Lonza and the government of South Africa to produce HIV medicines in that nation, where 5.6 million people are infected. "This joint venture, named Ketlaphela ["I will survive" in the Sotho language], will establish the first pharmaceutical plant to manufacture active pharmaceutical ingredients for antiretroviral medicines in South Africa," said Science Minister Naledi Pandor.

The plant will help control the price of AIDS drugs in South Africa, which currently imports the main ingredients needed. South Africa will invest 1.1 billion rand (US $143 million) in the project, while Lonza will commit 500 million rand (US $65 million), said Pandor.

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 
See Also
More on Generic/Discount HIV Drug Access in the Developing World

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement